Medical Information
Afrique
 

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
I am not a Healthcare ProfessionalNo, go back to the patient portal
SelectI am not a Healthcare ProfessionalNo, go back to the patient portal
Where do you work / live?
SubmitSubmit
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to selected congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.

Poster
Ramirez JA, Carrico R, Wilde A, Junkins A, Furmanek S, Chandler T, Schulz P, Hubler R, Peyrani P, Trivedi S, Liu Q, Uppal S, Gessner B, Begier E, and the NIDI RSV Study Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection

View Presentation
Oral Presentation
Walsh E, Polack F, Zareba AM, Falsey A, Marc GP, Jiang Q, Schneider K, Cooper D, Lino MM, Anderson A, Jansen KU, Swanson K, Gurtman A, Gruber W, Schmoele-Thoma B for the RENOIR Clinical Trial Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Efficacy and Safety of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine in Older Adults

View Presentation
Oral Presentation
Simões EAF, Madhi S, Paeds. F.C., Center KJ, Llapur C, Pizarro JN, Swanson KA, Radley D, McGrory SB, Gomme E, Scott DA, Jansen KU, Gruber WC, Gurtman AC October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

View Presentation
Poster
Law AW, Judy J, Willis SJ, Shea KM October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

High Maternal Tdap Vaccine Uptake During Early Part of Vaccination Window: Implications for Future Maternal Vaccines

View Presentation
Poster
Weycker D, Averin A, Houde L, Ottino K, Shea K, Gessner BD, Yacisin K, Curcio D, Begier B, Rozenbaum M October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years with and without Chronic Medical Conditions

View Presentation
Poster
McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, andFalsey AR October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis

View Presentation
Poster
Begier E, Hyams C, Healy W, Southern J, Adegbite D, Liu Q, Duale K, Chandler K, Hubler R, Oliver J, Morales-Aza B, Ellsbury G, Gessner B, Finn A February 24, 2023 ReSiVENT 2023 Respiratory Syncytial Virus

Adding Saliva Specimens Increases RT-PCR Detection of Respiratory Syncytial Virus Among Hospitalized Adults Over Nasopharyngeal Swabs Alone

View Presentation
Poster
Li Y, Kulkarni D, Begier E, Wahi-Singh P, Wahi-Singh B, Gessner B, Nair H February 24, 2023 ReSiVENT 2023 Respiratory Syncytial Virus

Adjusting for case under-ascertainment in estimating RSV hospitalizations burden of older adults in high-income countries: a systematic review and modelling study

View Presentation
Poster
Houde L, Averin A, Law A, Weycker D, Shea K February 24, 2023 ReSiVENT 2023 Respiratory Syncytial Virus

Annual Economic Burden of Respiratory Syncytial Virus Illness Among US Infants Aged <12 Months

View Presentation
Poster
Osei-Yeboah R, Amankwah S, Adedze M, Nyanzu F, Appiah P, Ansah JOB, Kenmoe S, Campbell H, Gessner B, Sato R, Begier B, Nair H February 24, 2023 ReSiVENT 2023 Respiratory Syncytial Virus

Burden Of Respiratory Syncytial Virus (RSV) Infection Among Adults Over 60 Years In Nursing And Care Homes: A Systematic Review

View Presentation